| Prenatal Diagnosis of Primary Immunodeficiency diseases (DNB 1994/2)10 | 164 | 1994 |
| Approach to a child with suspected immune dysfunction (DNB 2006/1)10 | 164 | 2006 |
| Investigations for suspected immunodeficiency (DNB 2018/2)5 | 164 | 2018 |
| Discuss CBC and ESR in evaluation of child with suspected immunodeficiency (DNB 2019/2)6 | 164 | 2019 |
| Approach to diagnosis and management of a child with suspected immune deficiency (DNB 2020/1)5 | 164 | 2020 |
| Primary Immunodeficiency - Management (DNB 2021/2)5 | 164 | 2021 |
| Approach to a suspected primary immunodeficiency disorder (DNB 2023/1)5 | 164 | 2023 |
| Screening for primary immunodeficiency (DNB 2024/2)5 | 164 | 2024 |
| Laboratory investigation of child suspected to have T-cell immunity Disorder (DNB 1993/1)15 | 165 | 1993 |
| Wiscott-Aldrich Syndrome (DNB 2016/1) | 165 | 2016 |
| Management of SCID (DNB 2017/2)5 | 165 | 2017 |
| Severe Combined Immunodeficiency (DNB 2022/1)5 | 165 | 2022 |
| Clinical features suggestive of T-cell defect (DNB 2022/2)5 | 165 | 2022 |
| Laboratory evaluation of suspected T-cell defect (DNB 2022/2)5 | 165 | 2022 |
| Diagnosis and treatment of severe combined immunodeficiency (SCID) (DNB 2023/2)5 | 165 | 2023 |
| Hyper IgE syndrome (DNB 2018/1)5, (DNB 2024/1)5 | 165 | 2018 |
| Enlist the humoral immunodeficiency disorders. Outline the diagnostic approach and treatment (DNB 2010/1)4+6 | 166 | 2010 |
| Discuss various components of primary immune deficiency, their clinical characteristics and investigations of a suspected predominant B-cell defect (DNB 2013/2)2+3+5 | 166 | 2013 |
| X linked Agammaglobulinemia (DNB 2018/2)5 | 166 | 2018 |
| Bruton's agammaglobulinemia (DNB 2024/2)5 | 166 | 2024 |
| Clinical features and laboratory findings in primary B cell immunodeficiency (DNB 2023/1)5 | 166 | 2023 |
| Numerate functions of the Phagocytes and Briefly describe defects of their functions (DNB 2009/1)4+6 | 170 | 2009 |
| Outline the characteristic features of primary immunodeficiency. Write in detail about pathogenesis and clinical features of chronic granulomatous disease (DNB 2011/1)4+3+3 | 170 | 2011 |
| Chronic granulomatous disease (DNB 2021/2)5 | 170 | 2021 |
| Define febrile neutropenia and describe the treatment and care of a child with febrile neutropenia (DNB 2008/1)10 | 171 | 2008 |
| Febrile neutopenia- Definition and management (DNB 2015/2)1+4 | 171 | 2015 |
| Febrile neutropenia (DNB 2020/1)5 | 171 | 2020 |
| Pathogenesis, clinical features and diagnostic criteria of autoimmune lymphoproliferative syndrome (DNB 2014/2)4+3+3 | 174 | 2014 |
| Describe the risks and benefits of bone marrow transplantation in children (DNB 1994/2)15 | 177 | 1994 |
| Bone marrow transplantation for children (DNB 2006/1)10 | 177 | 2006 |
| Enumerate the methods of harvesting/ storing stem cells. Outline the indications of stem cell therapy. Discuss in brief the patient preparation required for stem cell therapy. Enlist important potential complications of stem cell therapy (DNB 2011/1)2+3+3+2 | 177 | 2011 |
| Discuss the indications for stem cell transplantation therapy in children. What is its rationale and sources for stem cells? (DNB 2013/2)5+3+2 | 177 | 2013 |
| Stem cell therapy (DNB 2014/2)5 | 177 | 2014 |
| Principles of stem cell therapy (DNB 2018/2)5 | 177 | 2018 |
| Hematopoetic stem cell transplant (HSCT) (DNB 2019/2)4 | 177 | 2019 |
| Bone marrow transplant - Indications and complications (DNB 2021/2)5 | 177 | 2021 |
| Hemopoietic stem cell transplantation (DNB 2024/2)5 | 177 | 2024 |
| Graft versus host disease (DNB 1999/1)15 | 179 | 1999 |
| Discuss pathogenesis of Graft Versus Host Diseases (GVHD) Discuss clinical manifestations, staging and grading and management of acute GVHD (DNB 2013/2)2+3+2+3 | 179 | 2013 |
| What is the pathogenesis of graft vs host disease? What are its clinical manifestations? What measures can be taken to prevent it in case of stem cell transplantation? (DNB 2015/2)4+3+3 | 179 | 2015 |
| Graft vs Host Disease (DNB 2016/1)4 | 179 | 2016 |
| Screening for primary immunodeficiency (DNB 2024/2)5 | 164 | 2024 |
| Bruton's agammaglobulinemia (DNB 2024/2)5 | 166 | 2024 |
| Hematopoietic stem cell transplantation (DNB 2024/2)5 | 177 | 2024 |
| Hematopoietic stem cell transplantation in a child (DNB 2025/1)5 | 177 | 2025 |